Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  November 2014  »
MonTueWedThuFriSatSun
 12
3456789
10111213141516
17181920212223
24252627282930

Friends
    Links


    Entry 1 of 3187
    Last Page | Next Page
    10/12/2010 - ArQule and Daiichi Sankyo expand collaboration to produce drug candidates for cancer
    Posted in Medical News

    ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the scope of their research, chain and license agreement for the strike of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third restorative


    copyrights:cite this source synonym acquisition v1.1copyright � 2008 by lexico publishing


    copyrights:cite this source roget's ii: the new thesaurus group target, with an option for a fourth, in the field of oncology, and it includes a two-year realm based on the form of the proprietary ArQule Kinase Inhibitor scaffolding (AKIP™) technology.

    More: - The rest...

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb